TETERBORO, N.J., April 9 /PRNewswire-FirstCall/ -- Quest Diagnostics
Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing,
information and services, announced that Lucia Quinn, Senior Vice President,
Business Development, and Richard Bender, M.D., Medical Director,
Hematology/Oncology, are scheduled to speak at the Wachovia Securities Cancer
Diagnostics Conference on Thursday, April 10, 2003, at the Swissotel, in New
York City. The Quest Diagnostics presentation is scheduled to begin at 10:00
a.m. Eastern Time.
The presentation will be webcast live during the conference and will be
available to registered investors on the following site:
http://www.twst.com/econf/mm/fu12/dgx.html and to the public on
http://www.questdiagnostics.com. In addition, the archived webcast will be
available starting approximately 3 hours after the actual presentation time
and will be available for 60 days.
Quest Diagnostics Incorporated is the nation's leading provider of
diagnostic testing, information and services, providing insights that enable
physicians, hospitals, managed care organizations and other healthcare
professionals to make decisions to improve health. The company offers the
broadest access to diagnostic laboratory services through its national network
of laboratories and patient service centers. Quest Diagnostics is the leading
provider of esoteric testing, including gene-based medical testing, and
empowers healthcare organizations and clinicians with state-of-the-art
connectivity solutions that improve practice management. Additional company
information can be found on the Internet at: http://www.questdiagnostics.com.
The statements in this press release which are not historical facts or
information may be forward-looking statements. These forward-looking
statements involve risks and uncertainties that could cause actual results and
outcomes to be materially different. Certain of these risks and uncertainties
may include, but are not limited to, unanticipated expenditures, changing
relationships with customers, suppliers and strategic partners, conditions of
the economy and other factors described in the Quest Diagnostics Incorporated
2002 Form 10-K and subsequent filings.
SOURCE Quest Diagnostics Incorporated
/CONTACT: Investors - Laure Park, +1-201-393-5030, or Media - Gary
Samuels, +1-201-393-5700, both of Quest Diagnostics Incorporated/
/Web site: http://www.questdiagnostics.com /
/Video: http://www.twst.com/econf/mm/fu12/dgx.html /
(DGX)
CO: Quest Diagnostics Incorporated; Wachovia Securities
ST: New Jersey, New York
IN: MTC HEA BIO
SU: CCA BFA